Anzahl der Publikationen: 5
2016
Jedlickova, Z.; Schmid, C.; Koenecke, C.; Hertenstein, B.; Baurmann, H.; Schwerdtfeger, R.; Tischer, J.; Kolb, H.-J. und Schleuning, M.
(2016):
Long-term results of adjuvant donor lymphocyte transfusion in AML after allogeneic stem cell transplantation.
In: Bone Marrow Transplantation, Bd. 51, Nr. 5: S. 663-667
Heidenreich, S.; Ziagkos, D.; Biezen, A. van; Finke, J.; Platzbecker, U.; Niederwieser, D.; Einsele, H.; Bethge, W. A.; Schleuning, M.; Beelen, D. W.; Tischer, J.; Nagler, A.; Glass, B.; Maertens, J.; Richard, C.; Beguin, Y.; Sill, H.; Witte, T. de; Robin, M. und Kroeger, N.
(2016):
Allogeneic Stem Cell Transplantation for MDS Patients More Than 70 Years of Age: Update of a Retrospective Study of the MDS Subcommittee of the Chronic Malignancies Working Party (CMWP) of the EBMT.
In: Bone Marrow Transplantation, Bd. 51:
S510-S511
2008
Schmid, C.; Schleuning, M.; Hentrich, M.; Markl, G. E.; Gerbitz, A.; Tischer, J.; Ledderose, G.; Oruzio, D.; Hiddemann, Wolfgang und Kolb, H. J.
(2008):
High antileukemic efficacy of an intermediate intensity conditioning regimen for allogeneic stem cell transplantation in patients with high-risk acute myeloid leukemia in first complete remission.
In: Bone Marrow Transplantation, Bd. 41, Nr. 8: S. 721-727
2004
Schmid, C.; Schleuning, M.; Aschan, J.; Ringden, O.; Hahn, J.; Holler, E.; Hegenbart, U.; Niederwieser, D. W.; Dugas, Martin; Ledderose, G. und Kolb, H. J.
(2004):
Low-dose ARAC, donor cells, and GM-CSF for treatment of recurrent acute myeloid leukemia after allogeneic stem cell transplantation [2].
In: Leukemia, Bd. 18, Nr. 8: S. 1430-1433
1992
Schleuning, M.; Schmid-Haslbeck, M.; Utz, H.; Jochum, Marianne; Heim, M.; Mempel, W. und Wilmanns, W.
(Juni 1992):
Complement activation during storage of blood under normal blood bank conditions. Effects of proteinase inhibitors and of leukocyte depletion.
In: Blood, Bd. 79, Nr. 11: S. 3071-3075
[PDF, 1MB]
Diese Liste wurde am
Sat Nov 23 22:50:51 2024 CET
erstellt.